Previous close | 7.80 |
Open | 7.80 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 30.00 |
Expiry date | 2026-01-16 |
Day's range | 7.80 - 7.80 |
Contract range | N/A |
Volume | |
Open interest | 14 |
DUBLIN, May 28, 2024--Prothena today announced that Bristol Myers Squibb obtained the exclusive global license for PRX019 and will pay Prothena $80 million.
Celebrations may be in order for Prothena Corporation plc ( NASDAQ:PRTA ) shareholders, with the analysts delivering a...
The analysts might have been a bit too bullish on Prothena Corporation plc ( NASDAQ:PRTA ), given that the company fell...